Cocrystal Pharma, Inc. (NASDAQ:COCP – Get Free Report) shares fell 2.5% during trading on Thursday . The company traded as low as $1.50 and last traded at $1.55. 13,161 shares changed hands during mid-day trading, a decline of 51% from the average session volume of 26,677 shares. The stock had previously closed at $1.59.
Cocrystal Pharma Trading Down 2.5%
The firm has a fifty day moving average of $1.51 and a 200 day moving average of $1.76.
Cocrystal Pharma (NASDAQ:COCP – Get Free Report) last released its quarterly earnings data on Thursday, May 15th. The company reported ($0.23) EPS for the quarter, topping the consensus estimate of ($0.52) by $0.29. Analysts predict that Cocrystal Pharma, Inc. will post -1.85 EPS for the current year.
About Cocrystal Pharma
Cocrystal Pharma, Inc, a biotechnology company, focuses on the discovery and development of antiviral therapeutic treatments for serious and/or chronic viral diseases. It employs structure-based technologies to create antiviral drugs primarily to treat hepatitis C virus (HCV), influenza virus, coronavirus, norovirus, and respiratory virus infections.
Further Reading
- Five stocks we like better than Cocrystal Pharma
- Trading Stocks: RSI and Why it’s Useful
- Robinhood Director Sells Millions, But HOOD Stock Eyes Gains
- What is a Low P/E Ratio and What Does it Tell Investors?
- Coinbase Stock Pops as Senate Passes GENIUS Stablecoin Bill
- Where Do I Find 52-Week Highs and Lows?
- Super Micro Computer Stock’s Rally Backed by Strong Financials
Receive News & Ratings for Cocrystal Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cocrystal Pharma and related companies with MarketBeat.com's FREE daily email newsletter.